「age」の検索結果
17件：6～10件目を表示
もしかして
-
Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
with the law but will operate under a high standard of ethical values so as to conduct business management that is in line with the management philosophy of SENJU in order to develop and supply pharm...
https://www.senju.co.jp/english/about/csr03.html -
nding under the program Cyclic Innovation for Clinical Empowerment (CiCLE) established by the Japan Agency for Medical Research and Development (AMED). (1) Hayreh SS, and Zimmerman MB. Central retinal...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
ガチフロ点眼液0.3%
：国内第Ⅲ相一般臨床試験 （眼科周術期の無菌化療 法） （承認年月日：2004年 7 月 9 日、 申請資料概要ト1. （3） 4） ） 8） Hosaka M, et al.：Antimicrob Agents Chemother, 1992； 36：2108-2117 9） Takei M, et al.：Antimicrob Agents Chemother, 1998；42： 2678-2...
https://www.senju.co.jp/system/files/product_other_file/2024-02/gatiflo_202405_C9.pdf -
Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical
oducts includes a variety of specialized preparations formulated for different symptoms and patient age groups. Notable among these is our leading line of Mytear artificial tear-type eye drops, Japan&...
https://www.senju.co.jp/english/about/business/otc.html -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
を持つ創薬に取り組んでいます。 #9: Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic revie...
https://www.senju.co.jp/rd/policy/